Revive Therapeutics Ltd. Announces Results for Fiscal Year Ended June 30, 2014
Marketwired (press release)
Subsequent to its fiscal year end, on July 23, 2014, 296,387 broker warrants expiring on December 30, 2014 were exercised for 296,387 common shares of the Company at $0.30 per share for total proceeds of $88,916. Subsequent to its fiscal year end, …
After subscribing to the service (All Levels) this menu will become active to direct you to member database locations and weekly audio recordings. Please refresh the page if you have subscribed and are still seeing this message.